Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The reply.

The American journal of medicine·2026
Same author

The Clinical Spectrum of Paroxysmal Atrioventricular Block.

JAMA internal medicine·2026
Same author

What's your emergency?

The American journal of medicine·2025
Same author

Brugadaphobia.

The Journal of innovations in cardiac rhythm management·2025
Same author

Reverse Aslanger pattern vs. Littmann concept.

Journal of electrocardiology·2025
Same author

Volcanic mountain sign: A variant of the spiked helmet sign.

Journal of electrocardiology·2025
Same journal

Diagnosing heart failure through imaging.

Heart & lung : the journal of critical care·2026
Same journal

Comparative utility of median household income, social vulnerability index, and social deprivation index in predicting heart failure-related emergency department revisits: A multi-hospital cohort study.

Heart & lung : the journal of critical care·2026
Same journal

Predicting in-hospital mortality in AECOPD: A comparison of the mSOFA score with DECAF, Ottawa, and GOLD classifications.

Heart & lung : the journal of critical care·2026
Same journal

Diagnostic accuracy of serological tests and biomarkers for hypersensitivity pneumonitis: A systematic review.

Heart & lung : the journal of critical care·2026
Same journal

Associations of genetic risk factors and air pollution with incident pulmonary embolism: a prospective cohort study in the UK Biobank.

Heart & lung : the journal of critical care·2026
Same journal

Impaired hemostasis in mechanical circulatory support systems: Monitoring with T-TAS® 01, in vitro correction with VWF concentrates, and impact of membrane oxygenators.

Heart & lung : the journal of critical care·2026
See all related articles

Related Experiment Video

Updated: May 30, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Cardiorenal syndrome.

John Wynne1, Sara Y Narveson, Laszlo Littmann

  • 1Department of Internal Medicine, Carolinas Medical Center, Charlotte, North Carolina 28232, USA.

Heart & Lung : the Journal of Critical Care
|July 26, 2011
PubMed
Summary
This summary is machine-generated.

Cardiorenal syndrome, involving heart and kidney failure, presents complex challenges with limited treatments. Understanding underlying causes can help manage this condition, though effects may be transient.

More Related Videos

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
10:25

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury

Published on: August 30, 2011

Related Experiment Videos

Last Updated: May 30, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury
10:25

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury

Published on: August 30, 2011

Area of Science:

  • Cardiology
  • Nephrology
  • Critical Care Medicine

Background:

  • Cardiorenal syndrome (CRS) is a complex condition involving concurrent heart and kidney failure.
  • Pathophysiology and treatment options for CRS remain poorly understood.
  • Diuretic resistance and worsening renal function are common in decompensated CRS.

Observation:

  • This report details two patients hospitalized for decompensated heart failure.
  • Both patients developed diuretic resistance and rapidly declining kidney function.
  • The cardiorenal syndrome presented significant clinical challenges in both cases.

Findings:

  • Identifying and addressing the underlying causes of CRS was effective in the first patient.
  • In the second patient, understanding the cause provided only a temporary improvement.
  • The complex interplay between cardiac and renal systems in CRS necessitates individualized treatment approaches.

Implications:

  • Further research into the complex pathophysiology of cardiorenal syndrome is crucial.
  • Developing targeted therapies for CRS could improve patient outcomes.
  • This case series highlights the need for a deeper understanding of CRS to optimize patient management.